Medifast, Inc.
New York Stock ExchangeTotal Valuation
Medifast, Inc. carries a market capitalization of 114.08M, placing it among publicly traded companies globally. Its enterprise value stands at -40.81M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 114.08M |
| Enterprise Value | -40.81M |
Share Statistics
Medifast, Inc. currently has 11.12M shares outstanding.
| Shares Outstanding | 11.12M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Medifast, Inc. trades at a trailing price-to-earnings ratio of 646.81. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 0.72.
| PE Ratio | 646.81 |
| PS Ratio | 0.32 |
| PB Ratio | 0.72 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | 12.60 |
| P/OCF Ratio | 30.14 |
Enterprise Valuation
On an enterprise value basis, Medifast, Inc. trades at an EV/EBITDA multiple of 0.34 and an EV/FCF ratio of 0.52. The EV/Sales ratio of 0.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.01 |
| EV / EBITDA | 0.34 |
| EV / EBIT | 9.89 |
| EV / FCF | 0.52 |
Financial Position
Medifast, Inc. maintains a current ratio of 4.80, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.80 |
| Quick Ratio | 4.00 |
| Debt / Equity | 8.14 |
| Debt / EBITDA | -8.94 |
| Interest Coverage | N/A |
Financial Efficiency
Medifast, Inc. posts a return on equity of -12.05 and a return on invested capital of 1.27.
| Return on Equity (ROE) | -12.05 |
| Return on Assets (ROA) | -7.53 |
| Return on Invested Capital (ROIC) | 1.27 |
| Return on Capital Employed (ROCE) | 1.89 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.40 |
Taxes
Over the trailing twelve months, Medifast, Inc. has paid 11.92M in income taxes, reflecting an effective tax rate of 13.74.
| Income Tax | 11.92M |
| Effective Tax Rate | 13.74 |
Stock Price Statistics
Medifast, Inc.'s stock has declined approximately -22.50755% over the past 52 weeks. The 50-day moving average sits at 11.71, while the 200-day moving average is 11.41.
| Beta (5Y) | N/A |
| 52-Week Price Change | -22.50755% |
| 50-Day Moving Average | 11.71 |
| 200-Day Moving Average | 11.41 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medifast, Inc. generated 346.10M in revenue and converted that into -20.02M in net income, yielding earnings per share of -1.82. EBITDA reached -1.80M, while operating income came in at -16.24M.
| Revenue | 346.10M |
| Gross Profit | 242.70M |
| Operating Income | -16.24M |
| Pretax Income | -8.10M |
| Net Income | -20.02M |
| EBITDA | -1.80M |
| EBIT | -16.24M |
| Earnings Per Share (EPS) | -1.82 |
Balance Sheet
Medifast, Inc. holds 168.95M in cash and equivalents against 16.10M in total debt, resulting in a net debt position of -71.53M. Total book value stands at 156.16M, with working capital of 160.45M providing operational flexibility.
| Cash & Cash Equivalents | 168.95M |
| Total Debt | 16.10M |
| Net Debt | -71.53M |
| Equity (Book Value) | 156.16M |
| Book Value Per Share | 14.20 |
| Working Capital | 160.45M |
Cash Flow
Medifast, Inc. produced 3.72M in operating cash flow over the past twelve months. After subtracting -5.19M in capital expenditures, free cash flow totaled -1.47M - equivalent to -0.13 per share.
| Operating Cash Flow | 3.72M |
| Capital Expenditures | -5.19M |
| Free Cash Flow | -1.47M |
| FCF Per Share | -0.13 |
Margins
Medifast, Inc. operates with a gross margin of 70.12, reflecting its pricing power and cost economics. The operating margin of -4.69 and net profit margin of -5.78 provide insight into operational efficiency.
| Gross Margin | 70.12 |
| Operating Margin | -4.69 |
| Pretax Margin | -2.34 |
| Profit Margin | -5.78 |
| EBITDA Margin | -0.52 |
Dividends & Yields
The company's payout ratio of -0.44 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.01 |
| Dividend Yield | N/A |
| Payout Ratio | -0.44 |
| Shareholder Yield | 0.81 |
| FCF Yield | 7.94 |
Scores
Medifast, Inc. posts an Altman Z-Score of 4.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.03 |